Study #2023-0135
A pilot presurgical trial of REGN5678 (Anti-PSMA x CD28) in patients with high-risk, localized prostate cancer followed by radical prostatectomy
MD Anderson Study Status
Enrolling
Treatment Agent
REGN5678, Piflufolastat F18
Description
To learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Prostate Cancer, Radical Prostatectomy
Study phase:
Physician name:
Sumit Subudhi
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.